Peer Review reports
From: NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity
| Original Submission | ||
|---|---|---|
| 14 Oct 2016 | Submitted | Original manuscript |
| 25 Oct 2016 | Author responded | Author comments - Qijiong Li |
| Resubmission - Version 2 | ||
| 25 Oct 2016 | Submitted | Manuscript version 2 |
| 24 Nov 2016 | Reviewed | Reviewer Report - Li Che |
| 2 Dec 2016 | Reviewed | Reviewer Report - Junfang Ji |
| 26 Dec 2016 | Author responded | Author comments - Qijiong Li |
| Resubmission - Version 3 | ||
| 26 Dec 2016 | Submitted | Manuscript version 3 |
| 1 Jun 2017 | Author responded | Author comments - Qijiong Li |
| Resubmission - Version 4 | ||
| 1 Jun 2017 | Submitted | Manuscript version 4 |
| 19 Jun 2017 | Author responded | Author comments - Qijiong Li |
| Resubmission - Version 5 | ||
| 19 Jun 2017 | Submitted | Manuscript version 5 |
| 25 Jul 2017 | Author responded | Author comments - Qijiong Li |
| Resubmission - Version 6 | ||
| 25 Jul 2017 | Submitted | Manuscript version 6 |
| 5 Aug 2017 | Author responded | Author comments - Qijiong Li |
| Resubmission - Version 7 | ||
| 5 Aug 2017 | Submitted | Manuscript version 7 |
| 17 Aug 2017 | Author responded | Author comments - Qijiong Li |
| Resubmission - Version 8 | ||
| 17 Aug 2017 | Submitted | Manuscript version 8 |
| Publishing | ||
| 21 Aug 2017 | Editorially accepted | |
| 31 Aug 2017 | Article published | 10.1186/s12885-017-3570-4 |
You can find further information about peer review here.